Medreich Limited Bisoprolol Export Data — India (DGFT 2022–2026)

Name: Medreich Limited Bisoprolol Export Records India — #5 Exporter, 265 Shipments, $4.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Bisoprolol

India Pharmaceutical Trade Intelligence

$84.5M245 Suppliers121 CountriesHS 30049079

ExportsIndia → UNITED STATES34.4%India → CYPRUS19.4%

ImportsGERMANY → India$385.1K FRANCE → India$84.6K

#1 Supplier: UNICHEM LABORATORIES #1 Buyer: UNICHEM PHARMACEUTICALS

Medreich Limited — Bisoprolol Exporter #5 | $4.0M Trade Value | TransData Nexus | TransData Nexus

Medreich Limited — Bisoprolol Exporter Profile

Indian Pharmaceutical Exporter · #5 for Bisoprolol · $4.0M export value · DGFT Verified

Medreich Limited is the #5 Indian exporter of Bisoprolol with $4.0M in export value and 265 verified shipments. Medreich Limited holds a 4.8% market share in Bisoprolol exports across 10 countries. The company exports 42 pharmaceutical products worth $224.8M across 15 therapeutic categories.

Medreich Limited — Bisoprolol Export Profile: Buyers & Destinations

Medreich Limited Bisoprolol export treemap — buyers and destination countries | TransData Nexus

Where Does Medreich Limited Export Bisoprolol?

Country	Value	Shipments	Share
UNITED KINGDOM	$2.1M	137	53.7%
SINGAPORE	$721.7K	26	18.1%
POLAND	$305.5K	33	7.7%
NETHERLANDS	$291.3K	21	7.3%
UNITED ARAB EMIRATES	$225.6K

Who Are the Top Buyers of Bisoprolol from Medreich Limited?

Buyer	Country	Value	Orders
MEDREICH PLC	UNITED KINGDOM	$2.1M	137
PHARMAZEN MEDICALS PTE LTD.,	SINGAPORE	$395.3K	13
IMRES B V	NETHERLANDS	$291.3K	21
ZF POLPHARMA SA	POLAND	$282.2K	30
PHARMAZEN MEDICALS PTE LIMITED	SINGAPORE	$208.4K	6
IMPERIAL MEDRICAL SOLUTIONS FZE	UNITED ARAB EMIRATES	$147.6K	15
PHARMAZEN MEDICALS PTE LTD	SINGAPORE	$118.0K	7
MEDREICH AUSTRALIA PTY LTD	AUSTRALIA	$95.9K	7
GEMEFAR S.A.C	PERU	$39.4K	2
LIFEPHARMA FZE	UNITED ARAB EMIRATES	$35.1K	3

Medreich Limited supplies Bisoprolol to 22 buyers globally. The largest buyer is MEDREICH PLC (UNITED KINGDOM), followed by PHARMAZEN MEDICALS PTE LTD., (SINGAPORE) and IMRES B V (NETHERLANDS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Bisoprolol Formulations Does Medreich Limited Export?

Product Description / Formulation	Value	Shipments
BISOPROLOL FUMERATE FILM COATED TABLETS	$172.9K	9
BISOPROLOL FUMARATE TABLETS 2.5MG 2X14	$152.4K	6
BISOPROLOL FUMARATE FILM COATED TABLETS	$136.8K	5
BISOPROLOL TABLETS 5MG 2X14S (10549	$88.3K	4
BISOPROLOL FUMARATE TABLETS 1.25 MG (KE	$78.0K	6
BISOPROLOL TABLETS 5MG 2X14S (85000	$71.1K	4
BISOPROLOL TABLETS 5MG 2X14S (151592 PA	$63.4K	2
BISOPROLOL FUMARATE TABLETS 1.25MG 2X1	$54.6K	2
BISOPROLOL TABLETS 5MG 2X14S (115000	$53.7K	2
BISOPROLOL FUMARATE TABLETS 1.25MG (KEY	$53.2K	3

Medreich Limited exports 204 distinct Bisoprolol formulations including tablets, capsules, syrups, and combination drugs. The top formulation is BISOPROLOL FUMERATE FILM COATED TABLETS with 9 shipments worth $172.9K.

How Does Medreich Limited Compare to Nearest Bisoprolol Exporters?

Exporters ranked immediately above and below #5 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
3	IPCA LABORATORIES LIMITED	$9.1M	513	15	$17.8K
4	AUROBINDO PHARMA LTD	$4.8M	521	15	$9.2K
5	MEDREICH LIMITED ★	$4.0M	265	10	$15.3K
6	TORRENT PHARMACEUTICALS LTD	$3.4M	103	6	$33.4K
7	MYLAN LABORATORIES LIMITED	$2.2M	89	5	$24.5K

Medreich Limited ranks #5 among 245 Indian Bisoprolol exporters. Average shipment value of $15.3K compared to the market average of $220.4K. The closest competitors by value are IPCA LABORATORIES LIMITED and AUROBINDO PHARMA LTD.

Which Indian Ports Ship Bisoprolol Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	463	10.8%
SAHAR AIR	429	10.0%
JNPT/ NHAVA SHEVA SEA	407	9.5%
SAHAR AIR CARGO ACC (INBOM4)	368	8.6%
JNPT	247	5.8%
DELHI AIR	159	3.7%
HYDERABAD ICD	137	3.2%
BANGALORE ICD	134	3.1%

Geopolitical & Trade Policy Impact on Medreich Limited's Bisoprolol Exports

The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Medreich Limited. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased shipping costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structures of exporters relying on these routes. (sgeexport.com)

Conversely, the US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of tariffs on pharmaceutical imports by the US poses a risk to Indian companies, as higher tariffs could render low-margin generic drugs unprofitable, leading to market exits and exacerbating drug shortages in the US. (cfo.economictimes.indiatimes.com)

The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a favorable development for Medreich. The FTA eliminates tariffs on Indian pharmaceutical products entering the EU, providing immediate cost relief and enhancing market access. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, creating new opportunities for companies like Medreich to expand their presence in the EU market. (en.wikipedia.org)

Medreich Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The US Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent quality requirements that companies must adhere to for market access. Recent regulatory frameworks have increased compliance costs by an average of 18.7%, leading to a 15.2% reduction in export volumes to the US in the first quarter of 2025. (transdatanexus.com)

For Medreich Limited, maintaining compliance with these evolving standards is crucial to sustaining and expanding its export markets. Investments in quality assurance, regular audits, and staying abreast of regulatory changes are essential strategies to navigate this complex landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Bisoprolol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Medreich Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 265 individual customs records matching Medreich Limited exporting Bisoprolol, covering 204 formulations to 10 countries via 22 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 121+ countries, 585+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Bisoprolol

Bisoprolol

Medreich Limited — Bisoprolol Exporter Profile

Medreich Limited — Bisoprolol Export Profile: Buyers & Destinations

Where Does Medreich Limited Export Bisoprolol?

Who Are the Top Buyers of Bisoprolol from Medreich Limited?

What Is India's Total Bisoprolol Export Value and How Much Does Medreich Limited Contribute?

What Is the Average Shipment Value for Medreich Limited's Bisoprolol Exports?

How Does Medreich Limited Compare to Other Indian Bisoprolol Exporters?

What Bisoprolol Formulations Does Medreich Limited Export?

Regulatory Requirements: Exporting Bisoprolol to Key Markets

United Kingdom — MHRA

How Does Medreich Limited Compare to Nearest Bisoprolol Exporters?

Which Indian Ports Ship Bisoprolol Exports?

What Other Cardiovascular Products Does Medreich Limited Export?

Bisoprolol — Export Intelligence Video

Geopolitical & Trade Policy Impact on Medreich Limited's Bisoprolol Exports

Medreich Limited — Regulatory Compliance & Quality Standards

About Medreich Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Bisoprolol Export Data from Medreich Limited

Bisoprolol Stats

Company Overview

Top Products by Medreich Limited

Related Analysis

Need Detailed Export Data?

Data Source